Versor Investments
TECH icon

Versor Investments’s Bio-Techne TECH Stock Holding History

Versor Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.37M Sell
32,647
-9,403
-22% -$677K 3.96% 8
2026
Q2 		$2.97M Buy
+42,050
New +$2.27M 6.25% 3
2025
Q2 		– Sell
-40,386
Closed -$2.37M – 927
2025
Q1 		$2.37M Buy
+40,386
New +$2.74M 0.39% 31

Other funds holding TECH

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Versor Investments's TECH Position: Q3 2026 in Review

Versor Investments reduced its Bio-Techne (TECH) stake by 22% in Q3 2026, selling an estimated $677K and leaving 32,647 shares worth $2.37M. The position accounts for 3.96% of the portfolio, ranked #8.

Versor Investments first reported a position in TECH in Q1 2025 and has held it in 3 quarters since. The position peaked at $2.97M in Q2 2026. 402 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Versor Investments held 32,647 shares of Bio-Techne worth $2.37M as of Q3 2026.
  • Versor Investments sold 9,403 Bio-Techne shares in Q3 2026, an estimated $677K.
  • Bio-Techne made up 3.96% of Versor Investments's portfolio in Q3 2026, its #8 holding.
  • Versor Investments first reported a position in Bio-Techne in Q1 2025 and has held it in 3 quarters since.
  • Versor Investments's Bio-Techne position peaked at $2.97M in Q2 2026.
  • 402 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Versor Investments's 13F filing for Q3 2026, filed 23 Oct 2026.